How can clinicians learn to individualize hormonal therapys for your menopausal patients? What are the common symptoms? Host Dr. Prathima Setty welcomes Dr. Risa Kagan to discuss this important topic as well as, understanding the importance of understanding the difference between hormone-replacement therapy to hormone therapy. Dr. Kagan is Clinical Professor of the Departmient of Obstetrics, Gynecology, and Reproductive Sciences at the University of California, San Francisco, CA. She is a North American Menopause Society (NAMS) certified Menopause Practitioner and is certified by the International Society of Clinical Densitometry. She serves on national committees developing standards for menopause and osteoporosis care and is actively involved in several professional organizations including the North American Menopause Society where she was the 2005-2006 chair of the professional education committee.
The interview was conducted live at The North American Menopause Society (NAMS) meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org.